vs
BioNTech SE（BNTX）与Krystal Biotech, Inc.（KRYS）财务数据对比。点击上方公司名可切换其他公司
BioNTech SE的季度营收约是Krystal Biotech, Inc.的14.2倍（$1.5B vs $107.1M）。Krystal Biotech, Inc.净利率更高（48.0% vs -1.9%，领先49.9%）
BioNTech SE是总部位于德国美因茨的跨国生物技术企业，专注于免疫疗法及疫苗研发工作，核心研究方向覆盖肿瘤、传染性疾病等医疗领域，相关技术处于全球生物医药行业领先水平。
Krystal Biotech是一家处于临床阶段的生物技术企业，专注于研发和商业化针对罕见重症皮肤病的新型基因疗法，主要面向北美和欧洲市场，服务缺乏有效常规治疗方案的单基因皮肤病患者。
BNTX vs KRYS — 直观对比
营收规模更大
BNTX
是对方的14.2倍
$107.1M
净利率更高
KRYS
高出49.9%
-1.9%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $107.1M |
| 净利润 | $-28.7M | $51.4M |
| 毛利率 | — | — |
| 营业利润率 | -3.1% | 41.5% |
| 净利率 | -1.9% | 48.0% |
| 营收同比 | — | 17.5% |
| 净利润同比 | — | 13.0% |
| 每股收益（稀释后） | — | $1.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNTXKRYS
| Q4 25 | — | $107.1M | ||
| Q3 25 | $1.5B | $97.8M | ||
| Q2 25 | $260.8M | $96.0M | ||
| Q1 25 | $182.8M | $88.2M | ||
| Q4 24 | — | $91.1M | ||
| Q3 24 | $1.2B | $83.8M | ||
| Q2 24 | $128.7M | $70.3M | ||
| Q1 24 | $187.6M | $45.3M |
净利润BNTXKRYS
| Q4 25 | — | $51.4M | ||
| Q3 25 | $-28.7M | $79.4M | ||
| Q2 25 | $-386.6M | $38.3M | ||
| Q1 25 | $-415.8M | $35.7M | ||
| Q4 24 | — | $45.5M | ||
| Q3 24 | $198.1M | $27.2M | ||
| Q2 24 | — | $15.6M | ||
| Q1 24 | — | $932.0K |
营业利润率BNTXKRYS
| Q4 25 | — | 41.5% | ||
| Q3 25 | -3.1% | 42.3% | ||
| Q2 25 | -192.1% | 40.9% | ||
| Q1 25 | -292.2% | 41.0% | ||
| Q4 24 | — | 45.4% | ||
| Q3 24 | 0.8% | 26.8% | ||
| Q2 24 | -750.7% | 12.2% | ||
| Q1 24 | -270.4% | -14.8% |
净利率BNTXKRYS
| Q4 25 | — | 48.0% | ||
| Q3 25 | -1.9% | 81.2% | ||
| Q2 25 | -148.2% | 39.9% | ||
| Q1 25 | -227.5% | 40.5% | ||
| Q4 24 | — | 49.9% | ||
| Q3 24 | 15.9% | 32.4% | ||
| Q2 24 | — | 22.2% | ||
| Q1 24 | — | 2.1% |
每股收益（稀释后）BNTXKRYS
| Q4 25 | — | $1.69 | ||
| Q3 25 | — | $2.66 | ||
| Q2 25 | — | $1.29 | ||
| Q1 25 | — | $1.20 | ||
| Q4 24 | — | $1.53 | ||
| Q3 24 | — | $0.91 | ||
| Q2 24 | — | $0.53 | ||
| Q1 24 | — | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $496.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $1.2B |
| 总资产 | — | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BNTXKRYS
| Q4 25 | — | $496.3M | ||
| Q3 25 | — | $392.6M | ||
| Q2 25 | — | $353.8M | ||
| Q1 25 | — | $308.8M | ||
| Q4 24 | — | $344.9M | ||
| Q3 24 | — | $374.0M | ||
| Q2 24 | — | $345.8M | ||
| Q1 24 | — | $359.0M |
股东权益BNTXKRYS
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.0B | ||
| Q1 25 | — | $984.7M | ||
| Q4 24 | — | $946.4M | ||
| Q3 24 | — | $885.8M | ||
| Q2 24 | — | $838.9M | ||
| Q1 24 | — | $799.2M |
总资产BNTXKRYS
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $982.3M | ||
| Q2 24 | — | $917.7M | ||
| Q1 24 | — | $853.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $77.5M |
| 自由现金流经营现金流 - 资本支出 | — | $75.4M |
| 自由现金流率自由现金流/营收 | — | 70.4% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | — | $188.9M |
8季度趋势，按日历期对齐
经营现金流BNTXKRYS
| Q4 25 | — | $77.5M | ||
| Q3 25 | — | $39.7M | ||
| Q2 25 | — | $52.7M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $52.8M | ||
| Q3 24 | — | $58.9M | ||
| Q2 24 | — | $-4.2M | ||
| Q1 24 | — | $15.9M |
自由现金流BNTXKRYS
| Q4 25 | — | $75.4M | ||
| Q3 25 | — | $38.0M | ||
| Q2 25 | — | $50.8M | ||
| Q1 25 | — | $24.8M | ||
| Q4 24 | — | $52.0M | ||
| Q3 24 | — | $57.8M | ||
| Q2 24 | — | $-5.3M | ||
| Q1 24 | — | $14.6M |
自由现金流率BNTXKRYS
| Q4 25 | — | 70.4% | ||
| Q3 25 | — | 38.8% | ||
| Q2 25 | — | 52.9% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 57.1% | ||
| Q3 24 | — | 69.0% | ||
| Q2 24 | — | -7.5% | ||
| Q1 24 | — | 32.3% |
资本支出强度BNTXKRYS
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 2.8% |
现金转化率BNTXKRYS
| Q4 25 | — | 1.51× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 1.38× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | — | 1.16× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | -0.27× | ||
| Q1 24 | — | 17.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
